Previous 10 | Next 10 |
home / stock / irclf / irclf news
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that it has rescheduled its previously announced conference call to discuss the c...
Record fiscal year 202 2 revenue of $ 150 million Record fiscal year 202 2 Adjusted EBITDA * of $ 3 2 million Record fiscal year 202 2 net income of $ 17 million Generated $20 Million cas...
NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“ InterCure ” or the “ Company ”) the biggest and most profitable cannabis company outside of north America, announ...
NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Company ") announces that, further to the merger agreement with Cann Pharmaceutical Ltd. (“ Better ...
InterCure offers a pure play on the European cannabis market with a focus on Israel. The company went public via a SPAC in April and now trades below the PIPE price at only $8. The stock is cheap at only 2x EV/'22 sales targets. For further details see: InterCure: True I...
InterCure (IRCLF): Q1 Revenue of NIS 33.1M (+677.0% Y/Y)Positive cash flow from operations for the third consecutive quarter of NIS 8MEBITDA of NIS 9.5MShares +2.52%.Press Release For further details see: InterCure reports Q1 results
Today, Canada's cannabis companies are the only ones that trade on U.S. exchanges, but their businesses have struggled amid rampant oversupply. While U.S. cannabis companies are performing much better financially than their Canadian counterparts, their business is still illegal at the feder...
The ARK Invest Israel Innovation Technology ETF focuses on a single country that is, in and of itself, somewhat of a disruptive technology incubator. As you might expect, IZRL has been punched-in-the nose by the market rotation out of tech and into value, and is down 18% from its high...
A recent editorial by Anthony Varrell of technical420 reviews five emerging cannabis markets suggested as “need-to-watch” for investors in 2020. These include Colombia, Uruguay, Australia, Israel and China. The publication also highlights companies that are laser-focu...
HERZLIYA, Israel , Nov. 21, 2019 /PRNewswire/ -- Israeli medical cannabis company InterCure Ltd. (TASE: INCR) announced that its wholly-owned subsidiary Canndoc initiated a phase 3 clinical trial with the Shamir Medical Center ( Assaf HaRofeh ) f...
News, Short Squeeze, Breakout and More Instantly...
Intercure Ltd Company Name:
IRCLF Stock Symbol:
OTCMKTS Market:
NEW YORK and HERZLIYA, Israel , Oct. 31, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company&...
NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company in Israel and outside of North America, today addressed the status of the security ...
Achieved record revenues of NIS 209 million ($ 7 5 million) 1 for the first half of 2023 Annualized revenue run rate of NIS 41 7 million ($ 149 million) Adjusted EBITDA 2 of NIS 30 mill...